Cantargia (Cantargia AB); today announced new clinical results from two nadunolimab combination therapy trials in 54 patients. Positive signals of efficacy were documented in the key areas of ...

Promising Preclinical Results Position Ketamir-2 as a Potential Breakthrough Therapy That Surpasses Current Treatments, With Results to Be ...

Manur Multi Specialty Hospital successfully treats 14-year-old boy with Guillain-Barre Syndrome, AMSAN, and breathing issues.

GenSight Biologics' lead product candidate, GS010, is in Phase III trials in Leber Hereditary Optic Neuropathy (LHON), a rare mitochondrial disease that leads to irreversible blindness in teens and ...

Two decades ago, when two genetic mutations were discovered in Asia that gave scientists a better idea of how pain sensations ...

The nationwide recall of more than 7000 bottles of duloxetine delayed-release capsules is due to unacceptable levels of a ...

In today’s 2024 modern era, many people are experiencing constant foot discomfort and pain. Whether it is because of ...

For residents in North Houston and The Woodlands, relief from foot pain is within reach. Doctor's Inc. offers advanced, ...

From A+ skincare products to cleaning products that are super easy to use, products to help with cooking, and so much more.